| Poxvirus vectored cytomegalovirus vaccine to prevent cytomegalovirus viremia in transplant recipients: a phase 2, randomized clinical trial I Aldoss, C La Rosa, LR Baden, J Longmate, EJ Ariza-Heredia, WN Rida, ... Annals of internal medicine 172 (5), 306-316, 2020 | 62 | 2020 |
| Rapid acquisition of cytomegalovirus-specific T cells with a differentiated phenotype, in nonviremic hematopoietic stem transplant recipients vaccinated with CMVPepVax C La Rosa, J Longmate, CR Lingaraju, Q Zhou, T Kaltcheva, N Hardwick, ... Biology of Blood and Marrow Transplantation 25 (4), 771-784, 2019 | 16 | 2019 |
| CMV triplex vaccine to enhance adaptive NK and T-cell reconstitution after autologous hematopoietic cell transplantation A Rashidi, C La Rosa, J Curtsinger, Q Cao, Q Zhou, CR Lingaraju, ... Transplantation and cellular therapy 28 (6), 343. e1-343. e4, 2022 | 6 | 2022 |
| A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy of Cmvpepvax for Preventing CMV Reactivation/Disease after Matched Related … R Nakamura, C La Rosa, D Yang, JA Hill, A Rashidi, H Choe, Q Zhou, ... Blood 138, 2887, 2021 | 2 | 2021 |
| CTIM-29. CLINICAL EVALUATION OF CHLOROTOXIN-DIRECTED CAR T CELLS FOR PATIENTS WITH RECURRENT GLIOBLASTOMA RHG MENINGIOMAS Neuro-oncology, 2021 | 1 | 2021 |
| Vaccination of Hematopoietic Stem Cell (HCT) Donors with Triplex, a Novel Cytomegalovirus Vaccine: Safety, Feasibility and Adoptive Transfer of Protective CMV-Specific T Cells … R Nakamura, C La Rosa, I Aldoss, Q Zhou, CR Lingaraju, J Martinez, ... Blood 136, 33, 2020 | | 2020 |
| A phase II randomized, placebo-controlled, multicenter trial to evaluate the efficacy of cytomegalovirus PepVax vaccine in preventing cytomegalovirus reactivation and disease … R Nakamura, C La Rosa, D Yang, JA Hill, A Rashidi, H Choe, Q Zhou, ... Haematologica, 2020 | | 2020 |
| Biology of Blood and Marrow Transplantation C La Rosa, J Longmate, CR Lingaraju, Q Zhou, T Kaltcheva, N Hardwick, ... Biol Blood Marrow Transplant 25, 771À784, 2019 | | 2019 |
| Engineering influenza a/wsn/33 for in vivo bioluminescent imaging CR Lingaraju University of California, Los Angeles, 2014 | | 2014 |
